Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JNJ-95597528 in Inadequately Controlled Moderate to Severe Asthma
NCT07746687Phase 2Recruiting
- Sponsor
- Janssen Pharmaceutical
- Start
- Oct 2026
- Primary completion
- Sep 2029
- Countries
- 5
01
Overview
A Phase 2 trial of JNJ-95597528 in asthma, sponsored by Janssen Pharmaceutical. Started Oct 2026; status: recruiting.
02
Drugs
JNJ-95597528
03
Conditions
asthma
Beyond the preview
Go deeper on NCT07746687.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07746687.